Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

ExpreS2ion Biotech Holding

2.34 SEK

-20.41 %

Less than 1K followers

EXPRS2

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ExpreS2ion Biotech Holding

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue0.50.63.01.31.50.40.43.7
EBITDA-12.7-19.3-104.2-12.3-11.3-9.4-9.8-42.8
EBIT-13.1-19.7-67.7-12.7-11.7-9.7-10.2-44.3
EBIT-%-2,854.3 %-3,283.3 %-2,249.2 %-951.9 %-758.4 %-2,760.9 %-2,340.2 %-1,210.6 %
Profit before taxes-13.0-19.4-44.6-14.0-11.5-9.8-10.0-44.2
Net income-10.5-15.6-36.4-11.4-10.0-8.4-8.2-38.1
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.